Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study
To access this article, please choose from the options below
H.P.C. has received research funding from Amylin Pharmaceuticals, Inc. K.L., R.P., B.Z., and L.P. are all employees and stockholders of Amylin Pharmaceuticals, Inc.
PII: S0022-3476(09)00245-5
doi:10.1016/j.jpeds.2009.03.012
© 2009 Mosby, Inc. All rights reserved.
Refers to article:
- Pramlintide in Pediatric Type 1 Diabetes
